Study details
Enrolling now
Angiotensin-(1-7) Cardiovascular Effects in Aging
Milton S. Hershey Medical Center
NCT IDNCT05301192ClinicalTrials.gov data as of Apr 2026
Phase
EARLY_PHASE1
Target enrollment
26
Study length
about 4.1 years
Ages
65–80
Locations
1 site in PA
About this study
Researchers are testing whether angiotensin-(1-7), a protective hormone, can reduce cardiovascular sympathetic outflow and blood pressure. The trial will compare angiotensin-(1-7) to saline in older healthy adults.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Angiotensin-(1-7)
- 2.Take Saline
PhaseEARLY_Phase 1
DrugAngiotensin-(1-7)
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low11%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
angiotensin II
Endpoints
Secondary: Change in Heart Rate, Change in Heart Rate Variability, Change in Systolic and Diastolic Blood Pressure